Tengion Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 40

Employees

  • Stock Symbol
  • TNGNQ

Stock Symbol

Tengion General Information

Description

Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Contact Information

Website
www.tengion.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
GREY
Corporate Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
+1 (336) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tengion Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
331K

Tengion Financials Summary

In Thousands,
USD
TTM 30-Sep-2014 FY 2013 31-Dec-2013 FY 2012 31-Dec-2012 FY 2011 31-Dec-2011
EV 21,804 2,588 6,175 (2,938)
Revenue 0 0 0 0
EBITDA (56,419) (11,085) (13,543) (15,124)
Net Income (64,426) (18,927) (16,929) (19,061)
Total Assets 9,621 25,724 12,435 17,817
Total Debt 34,122 26,952 11,269 4,987
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tengion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tengion‘s full profile, request access.

Request a free trial

Tengion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing
Biotechnology
Winston-Salem, NC
40 As of 2014
00000
00000000000

000000

rure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat null
0000000000000
South San Francisco, CA
00000 As of 0000
00.000
00000 0000-00-00
00000000000 00.000

000000

ugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
0000000000000
Marietta, GA
000 As of 0000
00000
000000000 00 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tengion Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Mimedx Corporation Marietta, GA 000 00000 000000000 00 00000
You’re viewing 2 of 2 competitors. Get the full list »

Tengion Patents

Tengion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2016028575-A Smooth muscle cell constructs Pending 03-May-2010 00000000000
US-20110224800-A1 Cell-scaffold constructs Inactive 09-Mar-2010 00000000000 00
CA-2791736-A1 Cell-scaffold constructs Inactive 09-Mar-2010 00000000000
AU-2011224448-A1 Cell-scaffold constructs Inactive 09-Mar-2010 00000000000
EP-2544726-A1 Cell-scaffold constructs Inactive 09-Mar-2010 A61L27/3804
To view Tengion’s complete patent history, request access »

Tengion Executive Team (11)

Name Title Board Seat
Timothy Bertram Ph.D Chief Scientific Officer & President
A. Davis MD Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 2 of 11 executive team members. Get the full list »

Tengion Board Members (5)

Name Representing Role Since
00000 000000 Tengion Chairman & Board Member 000 0000
00000 0000000 Tengion Board Member 000 0000
0000000 00000 00 Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Tengion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tengion FAQs

  • When was Tengion founded?

    Tengion was founded in 2003.

  • Who is the founder of Tengion?

    Steven Nichtberger MD and Anthony Atala MD are the founders of Tengion.

  • Where is Tengion headquartered?

    Tengion is headquartered in Winston-Salem, NC.

  • What is the size of Tengion?

    Tengion has 40 total employees.

  • What industry is Tengion in?

    Tengion’s primary industry is Biotechnology.

  • Is Tengion a private or public company?

    Tengion is a Public company.

  • What is Tengion’s stock symbol?

    The ticker symbol for Tengion is TNGNQ.

  • Who are Tengion’s competitors?

    Genentech and Mimedx are competitors of Tengion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »